Corticosteroid-induced suppression of the cerebro-hypothalamo-pituitary-adrenal axis.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D002540:Cerebral Cortex / Q000187:drug effects* / Q000502:physiology; D002940:Circadian Rhythm; D005938:Glucocorticoids / Q000009:adverse effects* / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use / Q000652:urine; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects* / Q000502:physiology; D007328:Insulin; D008239:Lysine; D008797:Metyrapone; D010912:Pituitary-Adrenal Function Tests; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011749:Pyrogens; D011863:Radioimmunoassay; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014667:Vasopressins
D005938:Glucocorticoids; D007328:Insulin; D011749:Pyrogens; D014667:Vasopressins; D000324:Adrenocorticotropic Hormone; D008239:Lysine; D008797:Metyrapone